MarginsXMarginsX
Home › Markets › Health Care › RFL

Rafael Holdings Inc. (RFL)

RFL trades on NYSE in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$0.9701
-9.34% on the day
Market cap
$50.6M
Micro cap
Revenue · 2026
$874K
-4.7% on 2025
Net income · 2026
-$29.6M
-3390.7% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax), fiscal year ended 2026-07-31, https://www.sec.gov/Archives/edgar/data/1713863/000121390026113659/0001213900-26-113659-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2026-07-31.

Profile

FieldValue
TickerRFL on NYSE
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryUnited States
IPO year2018
SEC CIK0001713863
SEC industry codePharmaceutical Preparations
Incorporated inDE

Financials · 2026

LineValue
Revenue$874K
Net income-$29.6M
Operating income-$33.4M
Net margin-3390.7%
Operating margin-3822.5%
Revenue growth-4.7%
Cash$22.1M
Total assets$83.1M
P/E (computed)Net income was not positive
P/S (computed)57.9×

Warning signs

Cash runway
8.8 months
$22.1M cash at July 31, 2026
Share count, 1 year
+0.8%
2025-10-31 to 2026-10-31
Going-concern doubt
Yes
10-K filed October 29, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"As a result, management has concluded that substantial doubt exists regarding our ability to continue as a going concern for at least 12 months from the date of issuance of the accompanying consolidated financial statements."
10-K 2026-10-29
Cash and burn$22.1M cash; operating cash flow -$7.5M a quarter.Report 2026-07-31
Shares outstanding52,184,599 (2026-10-31); 51,770,804 a year earlier.Cover page 2026-10-31
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
Delisting25-NSE filed25-NSE 2025-12-11
AuditorCohnReznick LLP, Hartford, Connecticut, United StatesPCAOB Form AP 2026-11-11
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q4 2026
2026-07-31
Not filed-$9.2M-$8.4M$22.1M$608K$874K10-K 2026-10-29
Q3 2026
2026-04-30
$179K-$4.2M-$7.3M$30.5M$608K$980K10-Q 2026-06-11
Q2 2026
2026-01-31
$211K-$6.4M-$7.5M$37.8M$608K$1.2M10-Q 2026-03-16
Q1 2026
2025-10-31
$240K-$9.8M-$6.8M$45.5M$608K$1.0M10-Q 2025-12-12
Q4 2025
2025-07-31
$350K-$290K-$10.4M$52.8M$2.9M$917K10-K 2025-10-29
Q3 2025
2025-04-30
$362K-$4.8M-$3.2M$37.9M$2.3M$732K10-Q 2026-06-11
Q2 2025
2025-01-31
$77K-$4.6M-$2.3M$48.3M$4.0M$706K10-Q 2026-03-16
Q1 2025
2024-10-31
$128K-$9.0M-$3.0M$8.2M$4.0M$697K10-Q 2025-12-12

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document
PROSPECTUS
424B32025-05-06
Latest annual report
ANNUAL REPORT
10-K2026-10-29
Latest quarterly / interim
QUARTERLY REPORT
10-Q2026-06-11
Latest current report
CURRENT REPORT
8-K2026-11-09
Latest proxy
PROXY STATEMENT
DEF 14A2026-11-16

Source: SEC EDGAR submissions feed, 411 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+2.9%
1 month-28.2%
3 months-45.7%
Year to date-9.3%
1 year-15.1%
From 52-week high-71.7%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
QUCYQuantum Cyber N.V.$0.5850-7.58%$51.0M
IBIOiBio Inc.$0.7067-3.42%$49.8M
CTORCitius Oncology Inc.$0.5350-6.76%$49.7M
SDEVStablecoin Development Corporation$0.7055-9.55%$51.6M
APLMApollomics Inc.$17.84+0.91%$51.7M
MREOMereo BioPharma Group plc$0.3050-0.81%$48.7M
CLNNClene Inc.$3.66-6.63%$52.7M
HOWLWerewolf Therapeutics Inc.$0.9908+1.07%$48.2M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier